Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014-Reference-Cited by-同舟云学术

Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014

Published:2017-08-17 Issue:23 Volume:123 Page:4672-4679
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nixon Nancy A.¹^ORCID,Khan Omar F.¹^ORCID,Imam Hasiba²,Tang Patricia A.¹,Monzon Jose¹,Li Haocheng³⁴,Sun Gavin⁵,Ezeife Doreen¹,Parimi Sunil⁶,Dowden Scot³⁴,Tam Vincent C.³⁴

Affiliation:

1. Department of Oncology; Tom Baker Cancer Centre, University of Calgary; Calgary Alberta Canada

2. Department of Medicine; Cumming School of Medicine, University of Calgary; Calgary Alberta Canada

3. Department of Oncology; Cumming School of Medicine, University of Calgary; Calgary Alberta Canada

4. Department of Community Health; Cumming School of Medicine, University of Calgary; Calgary Alberta Canada

5. Department of Clinical Pharmacology and Toxicology; Schulich School of Medicine and Dentistry, Western University; London Ontario Canada

6. British Columbia Cancer Agency; Vancouver British Columbia Canada

Funder

University of Calgary

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30919/fullpdf

Reference26 articles.

1. Economic burden of cancer across the European Union: a population-based cost analysis;Luengo-Fernandez;Lancet Oncol.,2013

2. The future of drug development: advancing clinical trial design;Orloff;Nat Rev Drug Discov.,2009

3. Catalyzing the Critical Path Initiative: FDA's progress in drug development activities;Parekh;Clin Pharmacol Ther.,2015

4. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J Health Econ.,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-derived tumoroids and proteomic signatures: tools for early drug discovery;Frontiers in Immunology;2024-04-18

2. Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine;Biomedicines;2022-07-12

3. Lockdown, a selective small-molecule inhibitor of the integrin phosphatase PPM1F, blocks cancer cell invasion;Cell Chemical Biology;2022-06

4. R&D competition and the direction of innovation;International Journal of Industrial Organization;2022-05

5. CULTURE AND MAINTENANCE OF URINE-DERIVED, 3-DIMENSIONAL CANINE TRANSITIONAL CELL CARCINOMA ORGANOIDS;2021-08-24